av/erytech-pharma--big.svg

COM:ERYTECH

PHAXIAM Therapeutics

  • Stock

Last Close

0.80

28/06 15:35

Market Cap

48.66M

Beta: -

Volume Today

27.49K

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
1.80M
-
6.61M
266.92%
10.78M
62.95%
19.72M
82.99%
1.33M
-
cost of revenue
5.33M
-
6.61M
24.12%
10.78M
62.95%
19.72M
82.99%
25.46M
29.12%
33.47M
31.44%
52.19M
55.95%
57.58M
10.32%
1.61M
-
gross profit
-3.53M
-
-25.46M
-
-33.47M
31.44%
-52.19M
55.95%
-57.58M
10.32%
-282K
-
selling and marketing expenses
3.70M
-
general and administrative expenses
3.55M
-
4.36M
22.90%
7.62M
74.63%
6.66M
12.55%
8.52M
27.99%
14.60M
71.28%
17.16M
17.56%
14.97M
12.78%
15.10M
0.88%
13.89M
8.04%
10.26M
26.10%
selling general and administrative expenses
3.55M
-
4.36M
22.90%
7.62M
74.63%
6.66M
12.55%
8.52M
27.99%
14.60M
71.28%
17.16M
17.56%
14.97M
12.78%
15.10M
0.88%
13.89M
8.04%
13.97M
0.57%
research and development expenses
2.50M
-
52.19M
-
57.58M
10.32%
45.10M
21.67%
19.91M
55.86%
9.84M
50.56%
other expenses
-4.29M
-
-2.03M
52.83%
-2.81M
38.62%
-3.99M
42.06%
-3.10M
22.31%
-4.45M
43.50%
-5.28M
18.80%
-3.72M
29.62%
-3.69M
0.86%
-6.65M
80.33%
cost and expenses
7.09M
-
8.95M
26.30%
15.58M
74.15%
22.39M
43.67%
30.89M
37.95%
43.62M
41.23%
64.07M
46.89%
68.83M
7.43%
56.52M
17.89%
27.15M
51.96%
25.42M
6.37%
operating expenses
1.76M
-
2.34M
32.91%
4.81M
105.87%
2.67M
44.45%
5.42M
103.11%
10.15M
87.15%
64.07M
531.08%
68.83M
7.43%
56.52M
17.89%
27.15M
51.96%
23.81M
12.30%
interest expense
4.66K
-
6.80K
46.07%
5K
26.48%
4K
20%
15K
275%
9K
40%
1.53M
16,933.33%
5.35M
249.25%
2.14M
60.07%
1.36M
36.20%
196K
85.63%
ebitda
-8.00M
-
-8.60M
7.46%
-14.72M
71.26%
-21.47M
45.85%
-32.99M
53.61%
-37.42M
13.43%
-61.13M
63.37%
-67.94M
11.15%
-47.45M
30.15%
-22.69M
52.18%
-23.81M
4.91%
operating income
-7.09M
-
-8.95M
26.30%
-15.58M
74.15%
-22.39M
43.67%
-30.89M
37.95%
-43.62M
41.23%
-64.07M
46.89%
-68.83M
7.43%
-56.52M
17.89%
-2.80M
95.05%
-25.42M
809.05%
depreciation and amortization
180.30K
-
276.52K
53.37%
288K
4.15%
425K
47.57%
532K
25.18%
797K
49.81%
2.95M
269.76%
889K
69.83%
9.06M
919.12%
-19.90M
319.62%
1.61M
108.08%
total other income expenses net
-1.10M
-
68.17K
106.20%
568K
733.19%
488K
14.08%
-2.65M
642.21%
5.40M
304.04%
1.41M
73.81%
-4.46M
415.77%
2.72M
160.92%
3.09M
13.57%
683K
77.89%
income before tax
-8.18M
-
-8.88M
8.50%
-15.02M
69.10%
-21.90M
45.86%
-33.53M
53.10%
-38.22M
13.98%
-62.66M
63.94%
-73.30M
16.98%
-53.80M
26.61%
293K
100.54%
-24.73M
8,541.64%
income tax expense
-40.02K
-
-20.16K
49.63%
-3K
85.12%
10K
433.33%
-3K
130%
2K
166.67%
-1K
150%
3K
400%
2K
33.33%
521K
25,950%
-1.25M
339.16%
net income
-8.14M
-
-8.86M
8.78%
-15.01M
69.45%
-21.91M
45.96%
-33.53M
53.01%
-38.22M
14.00%
-62.66M
63.93%
-73.30M
16.98%
-53.80M
26.61%
-228K
99.58%
-23.49M
10,201.75%
weighted average shs out
4.69M
-
5.87M
25.37%
6.96M
18.43%
7.98M
14.75%
17.94M
124.68%
17.94M
0.00%
17.94M
0.00%
18.39M
2.50%
23.69M
28.86%
31.02M
30.91%
5.08M
83.62%
weighted average shs out dil
4.69M
-
5.87M
25.37%
6.96M
18.43%
7.98M
14.75%
17.94M
124.68%
17.94M
0.00%
17.94M
0.00%
18.39M
2.50%
23.69M
28.86%
31.02M
30.91%
5.08M
83.62%
eps
-1.74
-
-1.51
13.22%
-2.16
43.05%
-2.74
26.85%
-1.87
31.75%
-2.13
13.90%
-3.49
63.85%
-3.99
14.33%
-2.27
43.11%
-0.01
99.67%
-4.62
62,332.43%
epsdiluted
-1.74
-
-1.51
13.22%
-2.16
43.05%
-2.74
26.85%
-1.87
31.75%
-2.13
13.90%
-3.49
63.85%
-3.99
14.33%
-2.27
43.11%
-0.01
99.67%
-4.62
62,332.43%

All numbers in (except ratios and percentages)